BioSpace News Archive

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is excited to announce that its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has entered into a feasibility study agreement with Mitsubishi Tanabe Pharma Corporation, a global pharmaceutical company that develops and commercializes innovative therapies for patients addressing unmet medical needs, centered on its priority disease areas

DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”) announced today that it has entered into definitive agreements with investors providing for the sale and issuance of up to 19,587 shares of its Series C Convertible Preferred Stock

Virginia Cardiovascular Specialists (VCS), a leading cardiology practice in Richmond, VA, has deployed PatientKeeper® to enable its providers to have immediate access to patient records and to enter professional charges, anytime, anywhere, via mobile devices.

Central Texas Pain Center is pleased to announce that Dr. Gregory Yanez has joined their team of highly talented interventional pain doctors to provide high-quality, care to patients in the South Austin community.

Asia Green Biotechnology Corp. (“AGB” or the “Company”) (CSE:ASIA) is pleased to announce that it has entered an agreement with Pathway Rx Inc. (“Pathway Rx”) pursuant to which AGB is granted an exclusive license to clinically develop and commercialize the Cannabis sativa varieties to which Pathway Rx Inc. owns the rights for prevention and for treatment of COVID-19 and other infectious diseases.

IoT platforms have opened new windows of engagement in patient care, encompassing home, long-distance, and acute care.

McKesson is proud to announce that it has been named to the Diversity Best Practices (DBP) fourth annual Inclusion Index.

SQI Diagnostics, Inc. (“SQI” or the “Company”) (TSX-V: SQD; OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that the Company’s board of directors has appointed Robert L. Chioini as Chief Executive Officer

Therapure Biomanufacturing, a division of Therapure Biopharma Inc., announced today the signing of an agreement with VBI Vaccines Inc. for the manufacture of their coronavirus vaccine candidates